Flagship Pioneering Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 58
- Investments
- 316
- Portfolio
- 41
- Exits
- 143
Flagship Pioneering General Information
Description
Flagship Pioneering is a venture capital firm that seeks to invest in the health technologies and life science sectors. The firm was founded in 2000 and is based in Cambridge, Massachusetts.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 55 Cambridge Parkway
- Suite 800 East
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Flagship Pioneering Investments (316)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Tessera (Biotechnology) | 12-Jan-2021 | Later Stage VC | 00000 | Biotechnology | Generating Revenue | |
| 00000000 000000000 | 10-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Product Development | 000000 000000 00.0 |
| 0000000 (000000000 | 07-Jul-2020 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 000000 000000 00.0 |
| 000000 00000000000 | 22-Jun-2020 | 00000 00000 | 00000 | Other Agriculture | Generating Revenue | 00000000 000 00000000 00.0 |
| 0000 0000000000000 | 11-Jun-2020 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 0000000 0000 00 |
| 0000 000000000000 | 10-Dec-2019 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 000000 000000 00.0 |
| 000000 (0000 00000 | 08-Oct-2019 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 0000000 0000000000 00 |
| 0000000 0000000000 | 30-Aug-2019 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue/Not Profitable | 0000000 0000 00 |
| Inari | 29-Jul-2019 | Later Stage VC | 0000 | Other Agriculture | Generating Revenue | 00000 00000 00.0 |
| Valo Health | 05-Jul-2019 | Early Stage VC | 00000 | Drug Discovery | Startup | 00000 0000000 |
Flagship Pioneering Exits (142)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Sigilon Therapeutics | 04-Dec-2020 | IPO | 00000 |
| 0000000 0000000000 | 23-Oct-2020 | 000 | 00000 |
| 000000 | 14-Oct-2020 | 000 | 000.00 |
| 0000000 0000000000 | 20-May-2020 | 000000 0000000000 | 00.000 |
| 0000000 | 14-May-2020 | 000000 0000000000 | 000.00 |
| 000000 00000000000 | 28-Jan-2020 | 000000000 00000000 | 00000 |
| 00000 0000000000 ( | 20-Dec-2019 | 000000000000000000 | |
| 0000000000 | 01-Sep-2019 | 000000000000000000 | |
| Axcella | 09-May-2019 | IPO | 000.00 |
| TransMedics | 02-May-2019 | IPO | 0000 |
Flagship Pioneering Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Flagship Pioneering‘s full profile, request access.
Request a free trialFlagship Pioneering Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialFlagship Pioneering Team (132)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Noubar Afeyan Ph.D | Co-Founder & Chief Executive Officer | 00 | 0 | 00 | Cambridge, MA |
| Chuck Carelli | Chief Financial Officer | Cambridge, MA | |||
| Jeffery Moore | Chief Financial Officer, Flagship Labs | Cambridge, MA | |||
| Robert Rosiello | Executive Partner & Chief Operating Officer | 0 | Cambridge, MA | ||
| Edwin Kania Jr. | Co-Founder & Managing Partner | 00 | 0 | 0 | Cambridge, MA |
Flagship Pioneering Co-Investors (86)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 6 | 0 |
|
|
|
| Alexandria Venture Investments | 0 | 0 | 0 |
|
|
| Alaska Permanent Fund | 0 | 0 |
|
|
|
| Baillie Gifford | 0 | 0 |
|
|
|
| Polaris Partners | 0 | 0 | 0 |
|
|